Skip to content

Author

Payton Weltge

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Developing Novel Bispecific T-cell Engager Therapy by Concurrent Targeting GARP on Cancer Cells and Regulatory T cells 2258672

It is demonstrated that elevated GARP expression in human tumors correlates with poor survival and higher relapse rates after first-line therapies after first-line therapies, and the Anti-GARP/CD3 platform holds the promise as a novel therapy of cancer immunotherapy worthy for clinical translation.

Ziyu Wang, Yaa S Amankwah, J. Mandula et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.